Ticker brief
ZVRA ZEVRA THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$13.98
1 day
+1.2%
14 days
+8.4%
mkt cap
$826.4M
signals 14d
6
authors 14d
4
Sentiment — last 14 days
daily mean sentiment, 2026-06-20 → 2026-06-28 · now +0.55 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @TheLongInvest | C | -2.16 | 3 | +0.53 |
| @RichardMoglen | B | +2.06 | 1 | +0.00 |
| @TheValueTrade | C | +1.95 | 1 | +0.25 |
| @MarketMaestro1 | C | -1.27 | 1 | +0.55 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-28 | @MarketMaestro1 | +0.55 | States ZVRA has a BoS breakout. | +3.4% | tweet ↗ |
| 2026-06-24 | @TheValueTrade | +0.25 | Lists portfolio names as all green on the day. | +6.9% | tweet ↗ |
| 2026-06-24 | @TheLongInvest | +0.70 | Multiple tickers at stated prices are buys. — Explicit buy list with entry prices; capped to first six tickers. | +6.9% | tweet ↗ |
| 2026-06-23 | @RichardMoglen | +0.00 | Wide watchlist of tickers with no explicit stance; capped at first six. | +7.5% | tweet ↗ |
| 2026-06-22 | @TheLongInvest | +0.40 | Canaccord maintains ZVRA at Buy with $29 price target. | +10.5% | tweet ↗ |
| 2026-06-20 | @TheLongInvest | +0.50 | Promotes next watchlist/basket after citing prior bullish calls. | +8.4% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.